Overview:

Summary

Medical equipment offering, “South Africa Diabetes Care Devices Market Outlook to 2016” provides key market data on the South Africa diabetes care devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories - Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

• Market size and company share data for two diabetes care devices market categories - Glucose Monitoring and Insulin Delivery.

• Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within two market categories.

• Data from 2002 to 2009, forecast forward for 7 years to 2016.

• 2009 company shares and distribution shares data for each of the two market categories.

• Global corporate-level profiles of key companies operating within the South Africa diabetes care devices market. Key players covered include F. Hoffmann-La Roche Ltd., LifeScan, Inc., Bayer HealthCare AG, Abbott Laboratories, Medtronic, Inc., Becton, Dickinson and Company and Novo Nordisk A/S.

Reasons to buy

• Develop business strategies by identifying the key market categories and segments poised for strong growth.

• Develop market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the South Africa diabetes care devices competitive landscape.

• Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future. What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Companies Mentioned

F. Hoffmann-La Roche Ltd.
Bayer HealthCare AG
LifeScan, Inc.
Sanofi-Aventis
Novo Nordisk A/S
Eli Lilly and Company
B. Braun Melsungen AG
Medtronic, Inc.
Abbott Laboratories
Becton, Dickinson and Company
Smiths Medical
Terumo Corporation
ARKRAY, Inc.
Apex Biotechnology Corp.
Animas Corporation

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 What is This Report About?

3 Diabetes Care Devices In South Africa

3.1 Diabetes Care Devices, Market Segmentation

3.2 Diabetes Care Devices, South Africa, Overall Revenue ($m), 2002-2016

3.3 Diabetes Care Devices Market, South Africa, Revenue Mix ($m), 2009

3.4 Diabetes Care Devices Market, South Africa, Category Contribution (%), 2009

3.5 Diabetes Care Devices, South Africa, Category Volume (Units), 2002-2016

3.6 Diabetes Care Devices, South Africa, Company Share (2008-2009)

4 Glucose Monitoring In South Africa

4.1 Glucose Monitoring, Market Segmentation

4.2 Glucose Monitoring Market, South Africa, Revenue Mix ($m), 2009

4.3 Glucose Monitoring Market, South Africa, Category Contribution (%), 2009

4.4 Glucose Monitoring Overall Revenue (2002-2016)

4.5 Glucose Monitoring Overall Volume (2002-2016)

4.6 Glucose Monitoring Average Price (2002-2016)

4.7 Glucose Monitoring Distribution Share (2008-2009)

4.8 Glucose Monitoring, South Africa, Company Share (2008-2009)

5 Insulin Delivery In South Africa

5.1 Insulin Delivery, Market Segmentation

5.2 Insulin Delivery Market, South Africa, Revenue Mix ($m), 2009

5.3 Insulin Delivery Market, South Africa, Category Contribution (%), 2009

5.4 Insulin Delivery Overall Revenue (2002-2016)

5.4.1 Insulin Pens Revenue (2002-2016)

5.5 Insulin Delivery Overall Volume (2002-2016)

5.5.1 Insulin Pens Volume (2002-2016)

5.6 Insulin Delivery Average Price (2002-2016)

5.7 Insulin Delivery Distribution Share (2008-2009)

5.8 Insulin Delivery, South Africa, Company Share (2008-2009)

6 Overview of Key Companies in South Africa Diabetes Care Devices Market

6.1 F. Hoffmann-La Roche Ltd.

6.1.1 Company Overview

6.1.2 Share in the South Africa Diabetes Care Devices Market

6.2 Bayer HealthCare AG

6.2.1 Company Overview

6.2.2 Share in the South Africa Diabetes Care Devices Market

6.3 LifeScan, Inc.

6.3.1 Company Overview

6.3.2 Share in the South Africa Diabetes Care Devices Market

6.4 Sanofi-Aventis

6.4.1 Company Overview

6.4.2 Share in the South Africa Diabetes Care Devices Market

6.5 Novo Nordisk A/S

6.5.1 Company Overview

6.5.2 Share in the South Africa Diabetes Care Devices Market

6.6 Eli Lilly and Company

6.6.1 Company Overview

6.6.2 Share in the South Africa Diabetes Care Devices Market

6.7 B. Braun Melsungen AG

6.7.1 Company Overview

6.8 Medtronic, Inc.

6.8.1 Company Overview

6.9 Abbott Laboratories

6.9.1 Company Overview

6.10 Becton, Dickinson and Company

6.10.1 Company Overview

6.11 Smiths Medical

6.11.1 Company Overview

6.12 Terumo Corporation

6.12.1 Company Overview

6.13 ARKRAY, Inc.

6.13.1 Company Overview

6.14 Apex Biotechnology Corp.

6.14.1 Company Overview

6.15 Animas Corporation

6.15.1 Company Overview

 

7 Diabetes Care Devices Market Pipeline Products

8 Appendix

8.1 Definitions of Markets Covered in the Report

8.1.1 Diabetes Care Devices

8.2 Research Methodology

8.3 Secondary Research

8.4 Primary Research

8.5 Models

8.6 Forecasts

8.7 Expert Panels

8.8 GlobalData Consulting

8.9 Currency Conversion

8.10 Contact Us

8.11 Disclaimer

1.1 List of Tables

Table 1:Diabetes Care Devices, South Africa, Overall Revenue ($m), 2002-2016

Table 2: Diabetes Care Devices Market, South Africa, Category Contribution (%), 2009

Table 3:Diabetes Care Devices, South Africa, Cross-Segment Analysis, 2002-2016

Table 4:Diabetes Care Devices, South Africa, Overall Revenue ($m), Historic, 2002-2009

Table 5:Diabetes Care Devices, South Africa, Overall Revenue ($m), Forecast, 2009-2016

Table 6:Diabetes Care Devices, South Africa, Category Volume (Units), 2002-2016

Table 7:Diabetes Care Devices, South Africa, Category Volume (Units), Historic, 2002-2009

Table 8:Diabetes Care Devices, South Africa, Category Volume (Units), Forecast, 2009-2016

Table 9:Diabetes Care Devices, South Africa, Company Share by Revenue ($m), 2008-2009

Table 10: Glucose Monitoring Market, South Africa, Category Contribution (%), 2009

Table 11:Glucose Monitoring, South Africa, Revenue ($m) by Segment, Historic, 2002-2009

Table 12:Glucose Monitoring, South Africa, Revenue ($m) by Segment, Forecast, 2009-2016

Table 13:Glucose Monitoring, South Africa, Volume (Units) by Segment, Historic, 2002-2009

Table 14:Glucose Monitoring, South Africa, Volume (Units) by Segment, Forecast, 2009-2016

Table 15:Glucose Monitoring, South Africa, Average Price ($), Historic, 2002-2009

Table 16:Glucose Monitoring, South Africa, Average Price ($), Forecast, 2009-2016

Table 17:Glucose Monitoring, South Africa, Distribution Share by Revenue ($m), 2008-2009

Table 18:Glucose Monitoring, South Africa, Company Share by Revenue ($m), 2008-2009

Table 19: Insulin Delivery Market, South Africa, Category Contribution (%), 2009

Table 20:Insulin Delivery, South Africa, Revenue ($m) by Segment, Historic, 2002-2009

Table 21:Insulin Delivery, South Africa, Revenue ($m) by Segment, Forecast, 2009-2016

Table 22:Insulin Pens, South Africa, Revenue ($m) by Sub-Segment, Historic, 2002-2009

Table 23:Insulin Pens, South Africa, Revenue ($m) by Sub-Segment, Forecast, 2009-2016

Table 24:Insulin Delivery, South Africa, Volume (Units) by Segment, Historic, 2002-2009

Table 25:Insulin Delivery, South Africa, Volume (Units) by Segment, Forecast, 2009-2016

Table 26:Insulin Pens, South Africa, Volume (Units) by Sub-Segment, Historic, 2002-2009

Table 27:Insulin Pens, South Africa, Volume (Units) by Sub-Segment, Forecast, 2009-2016

Table 28:Insulin Delivery, South Africa, Average Price ($), Historic, 2002-2009

Table 29:Insulin Delivery, South Africa, Average Price ($), Forecast, 2009-2016

Table 30:Insulin Delivery, South Africa, Distribution Share by Revenue ($m), 2008-2009

Table 31:Insulin Delivery, South Africa, Company Share by Revenue ($m), 2008-2009

Table 32: Diabetes Care Devices Pipeline Products

Table 33: USD to Local Currency, South Africa, Average Actual Rate 2002-2009

1.2 List of Figures

Figure 1: Diabetes Care Devices, Market Segmentation

Figure 2: Diabetes Care Devices, South Africa, Overall Revenue ($m), 2002-2016

Figure 3: Diabetes Care Devices Market, South Africa, Revenue Mix ($m), 2009

Figure 4: Diabetes Care Devices Market, South Africa, Category Contribution (%), 2009

Figure 5: Diabetes Care Devices, South Africa, Cross-Segment Analysis, 2002-2016

Figure 6: Diabetes Care Devices, South Africa, Overall Revenue ($m), Historic, 2002-2009

Figure 7: Diabetes Care Devices, South Africa, Overall Revenue ($m), Forecast, 2009-2016

Figure 8: Diabetes Care Devices, South Africa, Category Volume (Units), 2002-2016

Figure 9: Diabetes Care Devices, South Africa, Category Volume (Units), Historic, 2002-2009

Figure 10: Diabetes Care Devices, South Africa, Category Volume (Units), Forecast, 2009-2016

Figure 11: Diabetes Care Devices, South Africa, Company Share (%), 2009

Figure 12: Glucose Monitoring, Market Segmentation

Figure 13: Glucose Monitoring Market, South Africa, Revenue Mix ($m), 2009

Figure 14: Glucose Monitoring Market, South Africa, Category Contribution (%), 2009

Figure 15: Glucose Monitoring, South Africa, Revenue ($m) by Segment, Historic, 2002-2009

Figure 16: Glucose Monitoring, South Africa, Revenue ($m) by Segment, Forecast, 2009-2016

Figure 17: Glucose Monitoring, South Africa, Volume (Units) by Segment, Historic, 2002-2009

Figure 18: Glucose Monitoring, South Africa, Volume (Units) by Segment, Forecast, 2009-2016

Figure 19: Glucose Monitoring, South Africa, Company Share (%), 2009

Figure 20: Insulin Delivery, Market Segmentation

Figure 21: Insulin Delivery Market, South Africa, Revenue Mix ($m), 2009

Figure 22: Insulin Delivery Market, South Africa, Category Contribution (%), 2009

Figure 23: Insulin Delivery, South Africa, Revenue ($m) by Segment, Historic, 2002-2009

Figure 24: Insulin Delivery, South Africa, Revenue ($m) by Segment, Forecast, 2009-2016

Figure 25: Insulin Pens, South Africa, Revenue ($m) by Sub-Segment, Historic, 2002-2009

Figure 26: Insulin Pens, South Africa, Revenue ($m) by Sub-Segment, Forecast, 2009-2016

Figure 27: Insulin Delivery, South Africa, Volume (Units) by Segment, Historic, 2002-2009

Figure 28: Insulin Delivery, South Africa, Volume (Units) by Segment, Forecast, 2009-2016

Figure 29: Insulin Pens, South Africa, Volume (Units) by Sub-Segment, Historic, 2002-2009

Figure 30: Insulin Pens, South Africa, Volume (Units) by Sub-Segment, Forecast, 2009-2016

Figure 31: Insulin Delivery, South Africa, Company Share (%), 2009

Figure 32: F. Hoffmann-La Roche Ltd, Company Share (%), South Africa Diabetes Care Devices Market, 2009

Figure 33: Bayer HealthCare AG, Company Share (%), South Africa Diabetes Care Devices Market, 2009

Figure 34: LifeScan, Inc., Company Share (%), South Africa Diabetes Care Devices Market, 2009

Figure 35: Sanofi-Aventis, Company Share (%), South Africa Diabetes Care Devices Market, 2009

Figure 36: Novo Nordisk A/S, Company Share (%), South Africa Diabetes Care Devices Market, 2009

Figure 37: Eli Lilly and Company, Company Share (%), South Africa Diabetes Care Devices Market, 2009

Figure 38: GlobalData Methodology